What researchers published on Pompe-betegség
1192 papers, newest first.
Showing 40 of 1192
Patient perspectives of participation in clinical studies in late-onset Pompe disease: Structured exit interviews from cipaglucosidase alfa plus miglustat studies.Therapeutic advances in rare disease
High-Risk Screening for Late-Onset Pompe Disease in Northern China: Prevalence, Genotypic Spectrum, and Diagnostic Challenges.JIMD reports
High-Fat, High-Protein, Carbohydrate-Restricted Dietary Interventions in Pompe Disease: A Case Series with Long-Term Follow-Up.Annals of nutrition & metabolism
A novel technology-driven enzyme replacement therapy for Pompe disease.Molecular therapy. Advances
ÁttekintésInfusion-associated reactions during enzyme replacement therapy in late-onset Pompe disease: a systematic review and proposed management algorithm.Molecular genetics and metabolism
EsetismertetésRecurrent Reactions to Enzyme Replacement Therapy in Infantile-Onset Pompe Disease: A Case of Immunologic Barriers to Drug Tolerance.American journal of medical genetics. Part A
EsetismertetésEarly Cardiac Involvement in Late-Onset Pompe Disease: A Case Report from an Iranian Consanguineous Family.Iranian journal of child neurology
Szisztematikus áttekintésThe Genetic Landscape of Pompe Disease in the Middle East, North Africa, and Turkey (MENAT Region): A Systematic Review of GAA Variants and Genotype-Phenotype Correlation.International journal of molecular sciences
Home-Based Versus Hospital-Based Administration of Enzyme Replacement Therapy for Late-Onset Pompe Disease in Greece: A Cost-Utility and Budget Impact Analysis.Applied health economics and health policy
Efficacy and safety of cipaglucosidase alfa plus miglustat in Japanese adults with late-onset Pompe disease: a case series from clinical trials.BMJ neurology open
ÁttekintésInfantile-Onset Pompe Disease: Current Therapeutic Landscape, Clinical Challenges, and Future Horizons.Cureus
Of Pompe and Circumstance: A Case Review of Late Onset Pompe Disease in a 52-Year-Old Male.Case reports in rheumatology
Evaluation of Pompe Disease from a Broad and Systemic Perspective.Journal of clinical practice and research
Identifying regulatory muscle processes in infantile and adult Pompe patients using a multi-omic and morphological approach.Brain pathology (Zurich, Switzerland)
Generation and characterization of a human iPSC line (XACHi022-A) derived from an asymptomatic carrier of the GAA c.2051C > A (p.P684Q) variant.Stem cell research
Two novel GAA missense variants and a known VUS in pompe disease: Functional characterization and pharmacological chaperone therapy.Genes & diseases
A High-Fat, High-Protein, Carbohydrate-Restricted Dietary Interventions in Pompe Disease: A Case Series with Long-Term Follow-Up.Annals of nutrition & metabolism
Nocturnal sleep abnormalities occur before motor function deterioration in early-treated patients with infantile-onset Pompe disease: a two-decade newborn screening cohort study.Neuromuscular disorders : NMD
Enzyme replacement therapy (ERT) combined with transient low-dose methotrexate (TLD-MTX) results in age- and disease-dependent immune profile changes in Infantile- vs. late-onset Pompe disease patients.Frontiers in immunology
EsetismertetésLate-Onset Pompe Disease.The New England journal of medicine
Megfigyeléses vizsgálatScreening for potential late-onset Pompe disease patients among individuals with suspected sleep apnea: A prospective, multicenter observational Cohort Study in Japan (PSSAP-J Study).Sleep & breathing = Schlaf & Atmung
Corrigendum to "Early detection in action: developing and refining newborn screening for Pompe disease in North Carolina" [Mol. Genet. Med. 149 (1-2) (2026) 110252].Molecular genetics and metabolism
Preliminary clinical application of two-dimensional speckle tracking echocardiography in adult-onset glycogen storage disease type II.Archives of physiology and biochemistry
The Effect of Anti-drug Antibodies on the Bioavailability of Alglucosidase Alfa in Classic Infantile Pompe Disease.BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy
ÁttekintésGenome Editing for Glycogen Storage Diseases.Journal of inherited metabolic disease
Epilepsy Is Part of the CNS Phenotype in Classic Infantile Pompe Disease.Neurology. Genetics
Early detection in action: developing and refining newborn screening for Pompe disease in North Carolina.Molecular genetics and metabolism
Functional characterization of 42 GAA missense variants using a validated in vitro cellular functional assay.Molecular genetics and metabolism
Nociceptive pain in late-onset Pompe disease: prevalence, distribution, and clinical correlates.Journal of neurology
GAA engineered to improve cellular uptake enhances correction in a preclinical hematopoietic stem cell gene therapy model of Pompe disease.Molecular therapy. Advances
A Protocol for Multidisciplinary Rehabilitation Combined with Enzyme Replacement Therapy for Ventilator Weaning in Late-Onset Pompe Disease.Journal of visualized experiments : JoVE
Pompe Disease: From a Cardiovascular Lens.Cardiology in review
Megfigyeléses vizsgálatExpiratory phase lung mechanics in late-onset Pompe disease: a multicenter study using oscillometry to identify specific breathing abnormalities.Orphanet journal of rare diseases
AAV9-mediated GAA gene therapy following enzyme replacement therapy discontinuation in children with infantile-onset Pompe disease.EClinicalMedicine
Disease duration and phenotypic heterogeneity in late-onset Pompe disease: Implications for individualized therapy.Molecular genetics and metabolism
ÁttekintésDefining the therapeutic corridor of stability in enzyme replacement therapy for Pompe disease: a position statement.Orphanet journal of rare diseases
Szisztematikus áttekintésCentral nervous system histopathological findings in classic infantile Pompe disease: a systematic review with clinical relevance.Journal of neurology
Home Infusion With Recombinant Human α-Glucosidase in Children With Pompe Disease: The Dutch Experience Over 20 Years Across the Spectrum From Classic Infantile to Late-Onset Phenotypes.BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy
Real-Life Effectiveness After Switching to Avalglucosidase Alfa in Late-Onset Pompe Disease Patients Worsening on Alglucosidase Alfa Therapy: A French Cohort Study.European journal of neurology
A disease progression model comparing the long-term mobility and respiratory outcomes of adults with late-onset Pompe disease receiving cipaglucosidase alfa plus miglustat versus alglucosidase alfa.Journal of comparative effectiveness research